International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg −1 per day starting dose of oral corticosteroids to treat bullous pemphigoid

0 avis

International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg −1 per day starting dose of oral corticosteroids to treat bullous pemphigoid

Archive ouverte

Edité par CCSD ; Wiley -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect

Archive ouverte | Chen, D.M. | CCSD

International audience

Update of the French recommendations for the management of pemphigus. Actualisation des recommandations françaises de traitement du pemphigus

Archive ouverte | Jelti, L. | CCSD

International audience

Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus

Archive ouverte | Boulard, C. | CCSD

International audience. BACKGROUND:Two pemphigus severity scores, Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI), have been proposed to provide an objective measure ...

Chargement des enrichissements...